Pharmacotherapies for Psychiatric Disorders: What Does the Future Hold

This presentation on pharmacotherapies for psychiatric disorders will review new and novel pharmacologics, including those currently in the clinic, in the pipeline, and treatments of the future. Covered topics include: depression, schizophrenia, bipolar, and ADHD.
Greg W. Mattingly, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.86 MB
Released: December 8, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Intra-Cellular Therapies, Inc.
Neurocrine Biosciences, Inc.
Sage Therapeutics
Sunovion
Supernus Pharmaceuticals, Inc.

Related Content

Expert guidance on accurately diagnosing bipolar depression in patients who may not present in a manic or hypomanic episode from Clinical Care Options (CCO)

Greg W. Mattingly, MD Released: July 6, 2022

Slides from a presentation that educates clinicians on the identification and management of tardive dyskinesia.

Christoph U. Correll, MD Robert O. Cotes, MD Released: May 11, 2022

Slides from a presentation that educates clinicians on antipsychotic treatment of schizophrenia.

Christoph U. Correll, MD Robert O. Cotes, MD Released: May 11, 2022

Slides from a presentation that educates clinicians on managing major depression.

Manish Jha, MD Greg W. Mattingly, MD Released: May 11, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings